Literature DB >> 21080376

The IgH 3' regulatory region and its implication in lymphomagenesis.

Christelle Vincent-Fabert1, Rémi Fiancette, Michel Cogné, Eric Pinaud, Yves Denizot.   

Abstract

The 3' regulatory region (3'RR) located downstream of the IgH gene is the master element that controls class switch recombination and sustains high-level transcription at the plasma-cell stage. This latter role suggests that the 3'RR may be involved in oncogene deregulation during the frequent IgH translocation events associated with B-cell malignancies. A convincing demonstration of the essential contribution of 3'RR in lymphomagenesis has been provided by transgenic animal models. The mouse 3'RR shares a strong structural homology with the regulatory regions located downstream of each human Cα gene. Mouse models exploring the role of the 3'RR in B-cell physiology and in malignancies should provide useful indications about the pathophysiology of human cell lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080376     DOI: 10.1002/eji.201040778

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  Enhancers located in heavy chain regulatory region (hs3a, hs1,2, hs3b, and hs4) are dispensable for diversity of VDJ recombination.

Authors:  Pauline Rouaud; Christelle Vincent-Fabert; Remi Fiancette; Michel Cogné; Eric Pinaud; Yves Denizot
Journal:  J Biol Chem       Date:  2012-01-23       Impact factor: 5.157

2.  Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting.

Authors:  Jie He; Omar Abdel-Wahab; Michelle K Nahas; Kai Wang; Raajit K Rampal; Andrew M Intlekofer; Jay Patel; Andrei Krivstov; Garrett M Frampton; Lauren E Young; Shan Zhong; Mark Bailey; Jared R White; Steven Roels; Jason Deffenbaugh; Alex Fichtenholtz; Timothy Brennan; Mark Rosenzweig; Kimberly Pelak; Kristina M Knapp; Kristina W Brennan; Amy L Donahue; Geneva Young; Lazaro Garcia; Selmira T Beckstrom; Mandy Zhao; Emily White; Vera Banning; Jamie Buell; Kiel Iwanik; Jeffrey S Ross; Deborah Morosini; Anas Younes; Alan M Hanash; Elisabeth Paietta; Kathryn Roberts; Charles Mullighan; Ahmet Dogan; Scott A Armstrong; Tariq Mughal; Jo-Anne Vergilio; Elaine Labrecque; Rachel Erlich; Christine Vietz; Roman Yelensky; Philip J Stephens; Vincent A Miller; Marcel R M van den Brink; Geoff A Otto; Doron Lipson; Ross L Levine
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

3.  Role of the Igh intronic enhancer Eμ in clonal selection at the pre-B to immature B cell transition.

Authors:  Cheng Peng; Laurel A Eckhardt
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

4.  Aryl hydrocarbon receptor-induced activation of the human IGH hs1.2 enhancer: Mutational analysis of putative regulatory binding motifs.

Authors:  Andrew D Snyder; Sharon D Ochs; Brooke E Johnson; Courtney E W Sulentic
Journal:  Mol Immunol       Date:  2020-03-06       Impact factor: 4.407

5.  Position and sequence conservation in Amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3'Regulatory Region.

Authors:  Pietro D'Addabbo; Moira Scascitelli; Vincenzo Giambra; Mariano Rocchi; Domenico Frezza
Journal:  BMC Evol Biol       Date:  2011-03-15       Impact factor: 3.260

6.  Mantle cell lymphoma-like lymphomas in c-myc-3'RR/p53+/- mice and c-myc-3'RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular origin.

Authors:  Pauline Rouaud; Rémi Fiancette; Christelle Vincent-Fabert; Virginie Magnone; Michel Cogné; Pierre Dubus; Yves Denizot
Journal:  Oncotarget       Date:  2012-05

Review 7.  Epigenetic Regulation of Individual Modules of the immunoglobulin heavy chain locus 3' Regulatory Region.

Authors:  Barbara K Birshtein
Journal:  Front Immunol       Date:  2014-04-21       Impact factor: 7.561

8.  Elucidation of the enigmatic IgD class-switch recombination via germline deletion of the IgH 3' regulatory region.

Authors:  Pauline Rouaud; Alexis Saintamand; Faten Saad; Claire Carrion; Sandrine Lecardeur; Michel Cogné; Yves Denizot
Journal:  J Exp Med       Date:  2014-04-21       Impact factor: 14.307

9.  Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.

Authors:  Ina Amarillo; Peter H Bui; Sibel Kantarci; Nagesh Rao; Brit S Shackley; Rolando García; Carlos A Tirado
Journal:  Mol Cytogenet       Date:  2013-02-01       Impact factor: 2.009

10.  Inter- and intratumoral heterogeneity of BCL2 correlates with IgH expression and prognosis in follicular lymphoma.

Authors:  A Barreca; C Martinengo; L Annaratone; L Righi; A Chiappella; M Ladetto; A Demurtas; L Chiusa; A Stacchini; N Crosetto; A van Oudenaarden; R Chiarle
Journal:  Blood Cancer J       Date:  2014-10-10       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.